ProShares UltraShort NASDAQ Biotechnology
6 hedge funds and large institutions have $385K invested in ProShares UltraShort NASDAQ Biotechnology in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 2 closing their positions.
Holders
6
Holders Change
–
Holders Change %
0%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
–
Reduced
3
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$289K |
| 2 |
2
Simplex Trading
Chicago,
Illinois
|
$1K |
Top Sellers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $289K | 17,360 | +17,360 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $92.6K | 5,564 | -7,164 | -56% |
|
3
Citigroup
New York
| $1.42K | 85 | – | – |
|
4
Morgan Stanley
New York
| $1.25K | 75 | -88 | -54% |
|
|
5
Simplex Trading
Chicago,
Illinois
| $1K | 69 | +69 | New |
|
6
UBS Group
Zurich,
Switzerland
| $17 | 1 | -13 | -93% |
|
7
IMC Chicago
Chicago,
Illinois
| – | – | -25,210 | Closed |
|
8
Citadel Advisors
Miami,
Florida
| – | – | -10,649 | Closed |
|
|
CFGS
9
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|